z-logo
open-access-imgOpen Access
Cerebral venous thrombosis occurring during oxymetholone therapy
Author(s) -
Gökçe Pınar Reis,
Ayşenur Bahadır,
Erol Erduran,
Tülay Kamaşak,
İlker Eyüboğlu
Publication year - 2017
Publication title -
medicine science | international medical journal
Language(s) - English
Resource type - Journals
ISSN - 2147-0634
DOI - 10.5455/medscience.2017.06.8618
Subject(s) - venous thrombosis , medicine , thrombosis , cardiology
Oxymetholone, an androgen analogue, is widely used in the treatment of Fanconi Aplastic Anemia (FAA). Androgen is known to cause cerebral venous thrombosis (CVT). A 9-year-old girl under monitoring with a diagnosis of FAA presented to our hospital with severe headache. She had been receiving oxymetholone therapy for 1 year. Neurological examination was normal. Superior sagittal sinus thrombosis was detected at magnetic resonance imagining (MRI) of the brain. The thrombosis was thought to be oxymetholone-related, and oxymetholone therapy was discontinued. The patient was started on enoxoparin therapy and the symptoms resolved. Control images 4 months later were normal. We think that the risk of venous thrombosis must be considered with administering oxymetholone therapy in patients with FAA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom